Ariana, Bruker, University Hospitals of Strasbourg, University of Strasbourg diagnostic news

Ariana launched its ExtempoNMR project, which is partnered with Bruker's Bruker Biospin subsidiary, the university and university hospitals, to develop a tool for in vitro cancerous tissue diagnosis during surgical procedures. The tool will be based on the detection of undisclosed metabolic biomarkers using Ariana's KEM data analytics technology and high-resolution magic angle spinning (HR-MAS) NMR technology. The project aims to develop a tool that can determine the malignancy of removed tissue, along with prognostic indicators, in less time than histopathological examinations, which take 20-30 minutes. ...